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Summary 
A diverse range of illnesses has been treated with honey since ancient civilizations. There has been growing interest by health care 
professionals in wound care products based on New Zealand manuka honey and Australian honey of similar Leptospermum spp. In Fiji, local 
honeys have been used in homes to treat diabetic foot ulcers which have failed to heal by conventional therapeutic methods. This suggests 
that Fiji honeys may confer antimicrobial activity against the isolates from diabetic foot ulcers and this inference was tested in this study. The 
antimicrobial activity of 30 natural and two processed honeys was determined using some clinical isolates from diabetic foot ulcers, namely: 
Staphylococcus aureus, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Klebsiella pneumoniae and Candida albicans.  The 
antimicrobial activity of the natural honeys, determined by an agar well diffusion assay and expressed as the concentration of phenol with 
equivalent activity, was found to be between 4.1 and 14.5% w/v phenol. The mean inhibitory concentrations (MIC) of the honeys determined 
by an agar incorporation technique, was found to range from 4.8% to more than 9.1% (v/v) honey (9.1% being the highest concentration 
tested). In comparison, the activities of two processed honeys were between 4.5 - 8.9% phenol equivalence and did not inhibit the clinical 
isolates from diabetic foot ulcers at the highest concentration of honey tested (9.1%). The results demonstrate that Fijian honeys could be 
utilized as a herbal remedy for the treatment of diabetic foot ulcers. However, to assess the potential of Fijian honeys on diabetic foot ulcers, 
there is a need for clinical trials on these wounds. 
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Introduction 
Although honey is known as a food, there is growing interest in the 
medicinal properties of honey and its role in the treatment of many 
different health problems. Honey has many therapeutic properties; 
however the antibacterial property of honey is one which has 
evoked great interest among researchers. The antimicrobial property 
of honey is dependent on several contributing factors. Low water 
content, high osmolarity (high sugar content) and low pH prevent 
the growth of many bacteria but do not fully account for the activity 
of the honeys. The hydrogen peroxide and non-peroxide 
phytochemical) components of honey contribute to its additional 
activity (Molan, 1992). About 70% of honey’s natural sugars are 
made up of glucose and fructose. The enzyme glucose oxidase which 
is introduced to the honey during nectar collection acts on  
glucose and produces gluconic acid and hydrogen peroxide upon  
dilution (White et al., 1963). In many honeys, heating at elevated 
temperatures destroys this hydrogen peroxide activity and it is also 
lost in the presence of catalase (an enzyme that degrades hydrogen 
peroxide and is present in wound fluid). Honeys that retain activity in 
the presence of catalase are said to have non-peroxide antibacterial 
activity, manuka honey from New Zealand being an example of a 
honey with a high level of such activity (Allen, et al., 1991). 
 There is increased development of resistance to every 
antibiotic introduced in clinical practice (Payne et al., 2007). Wound 
infections caused by drug-resistant organisms are common and lead 
to increased costs, morbidity and mortality. There is an urgent need 
for the discovery of new antibiotics with novel modes of action. 
Honey has been utilized as a wound care product and its usage as a 
wound healing agent is reported in the treatment of venous leg 
ulcers (Gethin & Cowman, 2008; Jull et al., 2008), burns 
(Subramanian, 1993), chronic leg ulcers (Oluwatosin et al., 2000), 
pressure ulcers (Weheida et al., 1991) and exit sites of central 
venous catheters (Johnson et al., 2005). There has been growing 
interest by health care professionals in wound-care products based 
on New Zealand Manuka honey and Australian honey of similar 
Leptospermum spp. (Molan and Betts, 2004). In Fiji, local honeys 
have been used in homes to treat diabetic foot ulcers (DFU) which 
have failed to heal by conventional therapeutic methods. This 
suggests that Fiji honeys may confer antimicrobial activity against 
the species infecting DFU and this inference was tested in this study. 
 Infected foot ulcers are a common cause of morbidity in 
diabetic patients leading to complications like gangrene and 
amputations. In Fiji, one in every five people has diabetes and the 
incidence of foot problems and amputations remains high. Full 
thickness penetration of the dermis of the foot of diabetic people 
allows colonization of microbial species and initiates a complex series 
of reactions which leads to transient wound contamination or clinical 
infection. The initial microbial burden is low in DFU; however lack of 
proper care promotes microbial density and diversity. Most of the DFU 
are polymicrobial in nature (Brodsky et al., 1991; Ramani et al., 1991; 
Criado et al., 1992; Pathare et al., 1998; Chincholikar & Pal, 2002; 
Viswanathan et al., 2002). It has been reported  that the prevalence 
of Staphylococcus aureus amongst Gram-positive bacteria and 
Pseudomonas aeruginosa amongst Gram-negative bacteria were the 
most dominant of the flora of DFU, followed by Klebsiella 
pnuemoniae, Escherichia coli, Proteus mirabilis and Candida albicans, 
(Bansal et al., 2008).  
 There are many published reports on the antimicrobial 
potency of honey against different microbes and some of these 
studies have included S. aureus (Cooper et al., 1999; Cooper et al., 
2002; Miorin et al., 2003; Al Waili, 2004; French et al., 2005;  
Basualdo et al., 2007; Mercan et al., 2007), P. aeruginosa (Cooper et 
al., 2002; Estrada et al., 2005; Boukraa et al., 2007; Mercan et al., 
2007; Mullai & Menon., 2007), E. coli (Estrada et al., 2005; Fangio et 
al., 2007; ), K. pnuemoniae (Al Waili, 2004; Estrada et al., 2005; 
Mercan et al., 2007), P. mirabilis (Al Waili, 2004; Estrada et al., 2005) 
and Candida species (Estrada et al., 2005; Mercan et al., 2007).  
 The aim of the present study was to compare the 
antimicrobial capacity of 30 unprocessed Fijian honeys produced by 
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Fig. 1. The map of Fiji Islands with marked locations showing the origin of the honey samples. 
honey bees (Apis mellifera) and two processed Fijian honeys 
through measurement of the zones of inhibition in an agar well 
diffusion assay, with reference to phenol as a standard antiseptic, 
testing them against the clinical isolates from DFU. The minimum 
inhibitory concentrations (MIC) of the 32 honeys were also 
determined against the same isolates.  
 
Materials and methods 
Honey Samples  
Thirty samples of raw honey were collected by the beekeepers and 
the National Apicultural Coordinator from different geographical 
regions in Fiji as shown on the map in Fig. 1. Two samples of 
processed honey were obtained from the supermarket.  The samples 
represented prominent bee farming industries in Fiji. The floral 
sources of the honeys were identified by the beekeepers (Table.1). 
Two samples from different suppliers of the same floral source were 
analyzed for comparison purposes. All of the samples were stored  
at room temperature and in the dark for 2 months until they were 
tested.  
 
Antimicrobial Activity  
The procedure used for evaluating antimicrobial activity was 
described by Allen and colleagues but without the inclusion of 
catalase (Allen et al., 1991). Whereas that method used only S. 
aureus, in this study six clinical isolates were used. The test 
organisms: S. aureus, E. coli, P. aeruginosa, P. mirabilis, K. 
pneumoniae and C. albicans were isolated from DFU of patients 
from CWM Hospital. The information on their identities and antibiotic 
sensitivities was provided by the Head Microbiologist. The organisms 
were stored on plates at 40C. Cultures were also stored in glycerol at 
-800C and sub cultured when required. 
 
Inoculum preparation: Each of the clinical isolates were 
inoculated into 10 ml of Trypticase Soy broth and grown at 370C for 
18 hours. A further working culture was prepared by inoculating  
200 µL from the overnight culture into 10 mL of Trypticase Soy 
broth and adjusted to 0.5 McFarland Standard (equivalent to 106 
Colony Forming Unit (CFU)/mL), and diluted further to set an 
inoculum density of 1x104 CFU/mL which was used for the test. 
 
Plate preparation: To prepare the assay plates 20 mL of nutrient 
agar (Merck) for each plate was sterilized and seeded with 100 µL 
inoculum adjusted to 1x104CFU/mL. 
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Preparation of honey samples: A 40% (v/v) stock was prepared 
which was further diluted to obtain other concentrations of (20%, 
10%, 5%, and 2.5%) v/v respectively. 
 
Preparation of phenol standards: Standards 1% - 19% were 
prepared from a 20% w/v solution of phenol (BDH analar grade 
reagent) in water. 
 
Sample and standard application: Wells with similar spacing were 
cut into the agar. Each sample and standard was tested in triplicate 
by adding to each well. 
 
Plate incubation: After application of samples and standards, the 
plates were incubated at 370C for 24 hrs compared to a control plate 
that had no honey. The zones of inhibition were observed for various 
concentrations of honey and phenol standards after the incubation 
period. 
 
Calculation of the antibacterial activity of honey 
The mean diameter of the clear zone around each phenol standard 
was measured and squared. From the graph of % phenol against the 
square of the mean diameter of the clear zone, the activity of each 
diluted honey sample was calculated. The activity was expressed as 
the equivalent phenol concentration (% w/v). 
 
Minimum Inhibitory Concentration (MIC) 
The MIC was determined as described by Mulu, Belay & Fetene 
(2004). This paper tested MIC of honey against all the clinical isolates 
except for C. albicans. 
 Mueller Hinton Agar (Merck) was sterilized and held in a water 
bath (45-50400C). Honeys were briefly heated to 400C to reduce  
viscosity and known volumes of honey were measured into 20 mL of 
molten media to give final concentrations of 2.4%, 3.6%, 4.8%, 
5.9%, 7.0%, and 9.1% (v/v). The plate was poured, allowed to set 
and seeded with bacteria adjusted at 1x104 CFU/ mL before 
incubation at 370C for 24h. The plates were observed for growth and 
the results of the MIC were reported as the lowest concentration of 
honey that completely inhibited visible growth. For the plates where 
growth was visible, the results were recorded as >9.1% v/v (highest 
concentration of honey tested). Plans were to select honeys with 
lower MIC values and include those in clinical trials, therefore the 
maximum concentration of honey used was 9.1%.  
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Sample Floral Source S.aureus E.coli P.aeruginosa K.pneumoniae P.mirabilis C.albicans 
1 Mango 4.9 6.4 ND 5.7 ND ND 
2 Coconut 6.7 5.2 ND 5.7 5.2 ND 
3 Lantana 12.7 6.8 11.9 13.8 ND 5.8 
4 Henna Plant 5.1 ND ND 7.2 5.8 ND 
5 Mile a minute ND ND ND 6.1 7.6 ND 
6 Mile a minute ND ND ND 7.3 ND ND 
7 Pawpaw 9.1 ND ND 11.3 ND ND 
8 Balsam ND 7.2 ND 5.7 4.8 ND 
9 Bush Thumbergia 12.4 1.3 6.9 5.7 5.6 4.9 
10 Dilo 8.0 ND ND 4.8 ND ND 
11 Mango 4.9 5.2 11.3 ND ND ND 
12 Vaivai 5.2 10.3 5.7 5.7 ND ND 
13 Dilo 7.8 ND 7.6 5.2 ND ND 
14 Balsam 5.6 4.7 ND 5.2 ND 4.2 
15 Mint Weed 13.5 ND 4.5 13.4 ND 4.3 
16 Mint Weed 14.5 11.0 4.8 5.7 6.8 6.8 
17 Bush Thumbergia 10.3 ND ND 11.4 8.9 8.5 
18 Lantana 12.1 7.8 10.2 10.1 10.3 6.4 
19 Pawpaw 9.4 5.1 4.9 9.3 9.5 7.8 
20 Passion Fruit 4.9 13.6 5.4 13.4 8.2 8.7 
21 Vaivai 5.4 10.1 4.1 12.6 14.1 7.2 
22 Marigold 7.3 11.8 4.9 6.1 7.6 9.7 
23 Orange 9.9 ND 4.5 10.0 9.9 9.2 
24 Coconut 6.5 ND 8.1 11.1 5.9 ND 
25 Hibiscus 8.2 12.9 ND 7.8 6.1 5.5 
26 Orange 9.4 11.5 7.4 7.2 ND 4.9 
27 Henna Plant 5.0 ND 5.3 5.7 5.6 6.1 
28 Hibiscus 8.6 ND ND ND ND 4.4 
29 Marigold 9.5 ND 4.9 5.4 4.7 ND 
30 Passion Fruit 4.8 ND 6.2 4.8 ND 4.7 
31 Processed A 5.3 6.5 4.7 4.9 6.1 ND 
32 Processed B 4.5 5.1 ND 5.3 8.9 5.9 
Mean - 7.6 5.2 4.8 7.3 4.6 4.4 
SD - 0.3 0.1 0.5 0.4 0.8 0.6 
Total Antimicrobial activity as % (w/v) phenol equivalent   
Table 1. Antimicrobial activities of Fijian Honeys against clinical isolates from DFU, measured by an agar well diffusion assay. The results 
are shown the concentration of a solution of phenol with the equivalent microbial activity. Values shown are the mean (± SD) of three  
determinations.  ND = Not Detectable, (less than 4.1% (w/v) phenol equivalent). 
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Table 2. The Mean Inhibitory Concentrations (MIC) of Fijian Honeys as determined by the agar incorporation technique. The results are 
shown as the minimum concentration of each honey that gave complete inhibition of each isolate from DFU. The values > 9.1% indicate that 
there was no inhibition at the highest concentration tested.  
Sample Floral Source S.aureus E.coli P.aeruginosa K.pneumoniae P.mirabilis C.albicans 
1 Mango >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
2 Coconut >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
3 Lantana 9.1 >9.1 4.8 7.0 >9.1 >9.1 
4 Henna Plant >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
5 Mile a minute >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
6 Mile a minute >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
7 Pawpaw 9.1 >9.1 >9.1 9.1 >9.1 >9.1 
8 Balsam >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
9 Bush Thumbergia 9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
10 Dilo >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
11 Mango >9.1 >9.1 5.9 >9.1 >9.1 >9.1 
12 Vaivai >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
13 Dilo >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
14 Balsam >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
15 Mint Weed 9.1 >9.1 >9.1 7.0 >9.1 >9.1 
16 Mint Weed 7.0 9.1 >9.1 >9.1 >9.1 >9.1 
17 Bush Thumbergia 9.1 >9.1 >9.1 9.1 >9.1 >9.1 
18 Lantana 9.1 >9.1 7.0 9.1 9.1 >9.1 
19 Pawpaw 9.1 >9.1 >9.1 9.1 9.1 >9.1 
20 Passion Fruit >9.1 9.1 >9.1 7.0 >9.1 >9.1 
21 Vaivai >9.1 9.1 >9.1 9.1 7.0 >9.1 
22 Marigold >9.1 9.1 >9.1 >9.1 >9.1 >9.1 
23 Orange 9.1 >9.1 >9.1 9.1 9.1 >9.1 
24 Coconut >9.1 >9.1 >9.1 9.1 >9.1 >9.1 
25 Hibiscus >9.1 9.1 >9.1 >9.1 >9.1 >9.1 
26 Orange 9.1 9.1 >9.1 >9.1 >9.1 >9.1 
27 Henna Plant >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
28 Hibiscus >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
29 Marigold 9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
30 Passion Fruit >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
31 Processed A >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
32 Processed B >9.1 >9.1 >9.1 >9.1 >9.1 >9.1 
SD - 0.5 0.3 0.4 0.6 0.3 0.6 
Mean Inhibitory Concentration (% v/v) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results  
Antimicrobial Activity 
The antimicrobial activity of the 32 Fijian honeys (natural and  
processed) against the clinical isolates of DFU is shown in Table 1, 
expressed as the concentration of phenol with activity equivalent to 
that of the undiluted honey (Allen et al., (1991). The lowest  
concentration of phenol standard which was able to produce  
detectable antimicrobial activity in this assay was 4.1% (w/v). The 
absence of zones of inhibition indicated that the activity could not be 
detected (ND) for these honeys as it was lower than 4.1% (w/v) 
phenol equivalent. 
 
Minimum Inhibitory Concentration  
The MIC’s of the 32 Fijian honeys tested against the clinical isolates 
from DFU showed marked variation between microorganisms (Table 
2). The 2 processed honeys did not inhibit any of the microbes at 
9.1% v/v, which is the highest concentration used for this assay. 
None of the honeys were able to inhibit C.albicans at 9.1% (v/v). 
The MIC values of the 30 natural honeys against the six microbes 
were between 4.8 and higher than 9.1% (v/v). 
 
Discussion  
In this study we have demonstrated that all the 32 Fijian honeys 
display antimicrobial activity against clinical isolates of DFU.  More 
than half of the honeys demonstrated activity equivalent to that of 
phenol between 4% and 12% (w/v) (Table 1). The MIC values  
indicate that most of the 30 natural honeys (Table 2) failed to inhibit 
the DFU clinical isolates tested here, (19 honeys against S. aureus,  
24 honeys against E. coli, 27 honeys against P. aeruginosa, 20  
honeys against K. pneumoniae, 26 honeys against P. mirabilis, and 
all the 30 honeys against C. albicans). The two processed honeys 
did not inhibit any of the microbes from DFU at the maximum  
concentration tested (9.1% v/v). These values for the antibacterial 
activity of Fijian honeys tested against S. aureus can be compared 
with those obtained by Allen et al. (1991) from testing 345 samples 
of New Zealand honeys by the same method. They found the  
median MIC value to be equivalent to 13.6% (w/v) phenol. The 
mean value from the testing against S. aureus in the present study, 
equivalent to 7.6% phenol, indicates that Fijian honeys are not as 
potently antibacterial as New Zealand honeys. This is also indicated 
by the finding that the most active of the 30 samples of unprocessed 
Fijian honey had an activity equivalent to only 14.5% (w/v) phenol, 
little more than the median activity for the New Zealand honeys.  
However, a larger number of samples would have to be tested  
before this could be concluded with certainty. 
 The MIC values found in the present study for Fijian honeys 
can be compared with those found by other authors for other  
honeys tested against S. aureus and P. aeruginosa, the dominant 
microbes in DFU (Bansal et al., 2008). Cooper et al. (1999) used a 
manuka honey (non-peroxide activity) and a pasture honey (hydrogen 
peroxide activity), each with a near median level of  
activity for that type of activity, testing it against 58 strains of  
coagulase-positive S. aureus, and found the MIC to range from 2% to 
3% (v/v) for the manuka honey and 3% to 4% (v/v) for the  
pasture honey. Similar honeys were also tested against 20 clinical 
isolates of Pseudomonas spp from infected wounds (Cooper, Molan 
and Harding, 2002) and against 17 strains of P. aeruginosa isolated 
from infected burns. (Cooper, Halas and Molan, 2002). Mean values 
for the MIC for both types of honey were 7% (v/v) for both studies. 
In comparison, the MIC values found in the present study in testing 
against S. aureus ranged from 7.0- >9.1% (v/v) and against P. 
aeruginosa were in the range 4.8- >9.1% v/v. The comparison again 
indicates that the Fijian honeys do not have a high level of  
antibacterial activity. However, the MIC values found indicate that it 
would be possible to select Fijian honeys that would completely  
inhibit the growth of bacteria even if the honey became diluted  
ten-fold when in use on infected ulcers. 
 A clinical trial would be needed using Fijian honey to discover 
whether the locally produced honey is suitable for resolving the  
problem of infected DFU in Fiji. There is no evidence from  
randomized controlled trials to evaluate the effectiveness of honey in 
the eradication of infection or healing of DFU. However, it was  
reported by Sahel (2004) that honey treatment of DFU gave better 
control of infection and reduced mean healing time and amputation 
rates, much better than that achieved with Povidone iodine /  
hydrogen peroxide. Gethin and Cowman (2008) recruited 180  
patients with venous leg ulcers. The patients represented some with 
diabetic ulcers. It was observed that manuka honey increased  
incidence of healing, gave effective desloughing and a lower  
incidence of infection than the control. In a non-comparative study of 
the use of honey as a wound dressing, Efem (1988) treated wounds 
of various etiology, including diabetic ulcers, with honey therapy. The 
results of this study indicated that honey promoted granulation and 
epithelization of the wounds, reduced odour and had a dehydrating 
effect on the wounds. Case studies have also shown that honey has 
rapid healing effects on DFU (Eddy et al., 2008).  
 The faster healing of DFU dressed with honey also may result 
from the anti-inflammatory and de-sloughing effects of honey. There 
are numerous reports of these effects being observed clinically in a 
variety of types of wound as a reduction in odema and pain (Molan, 
1999) and improvement in healing outcomes (Gethin & Cowman, 
2008). These beneficial effects of honey, and its lack of adverse  
effects on wounds (Molan, 1999), considered along with the findings 
from the present study, indicate that Fijian honeys can be regarded as 
a possible treatment option for DFU. The authors are  
currently recruiting participants for a randomized controlled trial to 
assess the efficacy of honey against DFU.  
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